76 related articles for article (PubMed ID: 1893322)
21. [Familial disorders of lipid metabolism in childhood].
Herrmann W; Biermann J
Z Arztl Fortbild (Jena); 1986; 80(17):725-8. PubMed ID: 3811401
[No Abstract] [Full Text] [Related]
22. The 15th annual meeting of the European Lipoprotein Club.
Aggerbeck LP; Angelin B; Armstrong V; Franceschini G; Humphries S; Rosseneu M; Soutar A; Zechner R
Arterioscler Thromb; 1993 Apr; 13(4):618-27. PubMed ID: 8385481
[No Abstract] [Full Text] [Related]
23. Biological modification of lipoproteins and its role in atherogenesis.
Carew TE; Parthasarathy S
Agents Actions Suppl; 1988; 26():191-200. PubMed ID: 3265277
[No Abstract] [Full Text] [Related]
24. Familial combined hyperlipidemia. Part I. Lipid values and the lipoprotein pattern.
Vaverková H; Weinbergová O; Horcicka V; Kubasta M; Vrublovský P
Acta Univ Palacki Olomuc Fac Med; 1986; 113():193-216. PubMed ID: 2941985
[No Abstract] [Full Text] [Related]
25. [Familial combined hyperlipidemia: detection and characterisation of the hyperlipidemic profile among children and adolescents].
Ribalta J; La Ville AE; Heras M; Plana N; Masana L
Med Clin (Barc); 1997 Jun; 109(5):161-4. PubMed ID: 9289537
[TBL] [Abstract][Full Text] [Related]
26. Genetic basis of atherosclerosis: part I: new genes and pathways.
Lusis AJ; Fogelman AM; Fonarow GC
Circulation; 2004 Sep; 110(13):1868-73. PubMed ID: 15451808
[No Abstract] [Full Text] [Related]
27. Gender differences in postprandial ketone bodies in normolipidemic subjects and in untreated patients with familial combined hyperlipidemia.
Halkes CJ; van Dijk H; Verseyden C; de Jaegere PP; Plokker HW; Meijssen S; Erkelens DW; Cabezas MC
Arterioscler Thromb Vasc Biol; 2003 Oct; 23(10):1875-80. PubMed ID: 12933534
[TBL] [Abstract][Full Text] [Related]
28. [Primary hyperlipoproteinemias. Clinical, biological and physiopathological aspects].
Bakir R; Chanu B; Rouffy J
Pathol Biol (Paris); 1983 Apr; 31(4):248-58. PubMed ID: 6346238
[TBL] [Abstract][Full Text] [Related]
29. Type III hyperlipoproteinemia: recent insights into the genetic defect of familial dysbetalipoproteinemia.
Mahley RW; Angelin B
Adv Intern Med; 1984; 29():385-411. PubMed ID: 6369930
[No Abstract] [Full Text] [Related]
30. Single nucleotide polymorphisms of the very low density lipoprotein receptor (VLDLR) gene.
Near SE; Wang J; Hegele RA
J Hum Genet; 2001; 46(8):490-3. PubMed ID: 11501949
[TBL] [Abstract][Full Text] [Related]
31. Low-density lipoprotein (LDL) receptors and the regulation of serum LDL levels.
Vermeer BJ
Neth J Med; 1985; 28(2):52-8. PubMed ID: 3919323
[No Abstract] [Full Text] [Related]
32. Apolipoprotein E (role in lipoprotein metabolism and pathophysiology of hyperlipoproteinemia type III).
Utermann G
Ric Clin Lab; 1982; 12(1):23-30. PubMed ID: 6283616
[No Abstract] [Full Text] [Related]
33. How should FCHL be defined and how should we think about its metabolic bases?
Sniderman AD; Ribalta J; Castro Cabezas M
Nutr Metab Cardiovasc Dis; 2001 Aug; 11(4):259-73. PubMed ID: 11831111
[No Abstract] [Full Text] [Related]
34. Effect of diet on serum lipoproteins in children with various forms of hyperlipidemias.
Widhalm K
Prog Clin Biol Res; 1985; 188():145-59. PubMed ID: 3903768
[No Abstract] [Full Text] [Related]
35. [Lipid metabolism disorders--diagnosis and therapy in general practice. 8: Mixed hyperlipoproteinemias].
Richter WO
Fortschr Med; 1996 Jul; 114(18-19):248-50. PubMed ID: 8766794
[No Abstract] [Full Text] [Related]
36. Familial combined hyperlipoproteinemia.
Spence JD
CMAJ; 1992 Feb; 146(4):436, 438. PubMed ID: 1737299
[No Abstract] [Full Text] [Related]
37. [Diagnosis, clinical features and treatment of hyperlipidemias in children].
Widhalm K
Monatsschr Kinderheilkd; 1982 Oct; 130(10):747-52. PubMed ID: 7177116
[TBL] [Abstract][Full Text] [Related]
38. USF1 implicated in the aetiology of familial combined hyperlipidaemia and the metabolic syndrome.
Shoulders CC; Naoumova RP
Trends Mol Med; 2004 Aug; 10(8):362-5. PubMed ID: 15310455
[TBL] [Abstract][Full Text] [Related]
39. [DNA oxidation is a potential cardiovascular risk factor in combined familiar hyperlipemia].
Civeira F; Cenarro A
Med Clin (Barc); 2008 Jun; 131(1):14-5. PubMed ID: 18582418
[No Abstract] [Full Text] [Related]
40. Familial combined hyperlipoproteinemia.
Genest J
CMAJ; 1991 Sep; 145(6):664. PubMed ID: 1893322
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
